Pdt Partners, LLC Biogen Inc. Transaction History

Pdt Partners, LLC

$1.02 Billion
Q3 2024

A detailed history of Pdt Partners, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 16,497 shares of BIIB stock, worth $2.46 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

16,497

Previous 6,500 153.8%

Holding current value

$2.46 Million

Previous $1.51 Million 112.28%

% of portfolio

0.31%

Previous 0.15%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $1.89 Million - $2.37 Million	9,997 Added 153.8%	16,497 $3.2 Million
Q2 2024 Aug 15, 2024	BUY	$190.52 - $236.72 $1.24 Million - $1.54 Million	6,500 New	6,500 $1.51 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $1.01 Million - $1.21 Million	4,525 Added 282.81%	6,125 $1.58 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $405,280 - $457,424	1,600 New	1,600 $411,000
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $779,685 - $888,421	3,039 New	3,039 $844,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $228,760 - $315,440	1,175 New	1,175 $314,000
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $1.23 Million - $1.46 Million	-6,544 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $793,875 - $1 Million	4,097 Added 167.43%	6,544 $1.38 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $547,932 - $704,173	2,447 New	2,447 $587,000
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $6.5 Million - $9.78 Million	-27,513 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $529 - $611	-2 Reduced 0.01%	27,513 $7.81 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $1.84 Million - $2.43 Million	-7,107 Reduced 20.53%	27,515 $7.36 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $672,393 - $852,941	2,501 Added 7.79%	34,622 $11 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $2.28 Million - $3.16 Million	-10,379 Reduced 24.42%	32,121 $9.53 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $9.32 Million - $10.3 Million	42,500 New	42,500 $9.94 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $11.7 Million - $15.3 Million	-39,800 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $4.03 Million - $5.7 Million	-15,500 Reduced 28.03%	39,800 $10.9 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $3.88 Million - $4.34 Million	12,600 Added 29.51%	55,300 $17.6 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $12 Million - $14.1 Million	42,700	42,700 $13.4 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account